Navigate the Sarepta Therapeutics $SRPT and etepliren information pages
Your source for all relevant information for the DMD and investment communities interested in eteplirsen.
Note the company was formerly know as AVI BioPharma $AVII
Introduction
Webcasts and Events
Stock Analysis and Reporting
Eteplirsen Info
Media Reports and Patient Testimonials
Scientific and Medical Presentations
DMD and Competition
Infectious Disease Pipeline
Get first-hand perspective and education information from an inspiring family with two boys with DMD, plus learn how you can make a difference - visit www.DMDHero.com
Note the company was formerly know as AVI BioPharma $AVII
Introduction
Webcasts and Events
Stock Analysis and Reporting
Eteplirsen Info
Media Reports and Patient Testimonials
Scientific and Medical Presentations
DMD and Competition
Infectious Disease Pipeline
Get first-hand perspective and education information from an inspiring family with two boys with DMD, plus learn how you can make a difference - visit www.DMDHero.com
This page still under construction - check back for updates!
We here at BiotechDueDiligence are always staying on top of the hot topics in the world of biotech investing. Right now, hands down that is Sarepta Therapeutics $SRPT and their promising early data for their drug eteplirsen for Duchenne Muscular Dystrophy (DMD) a devastating, fatal disease in young boys. Please navigate these pages to catch up on all of the latest news including webcasts, media reports, scientific presentations, regulatory information, and more.
If there is a link, file, etc that we have missed, please Contact Us. Thanks in advance, and feel free to share this resource with anyone who may be interested!
If there is a link, file, etc that we have missed, please Contact Us. Thanks in advance, and feel free to share this resource with anyone who may be interested!